Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Injectable forms generally produce the most predictable and well-studied outcomes
While both medications contain the same active ingredient, semaglutide, their different forms of administration offer flexibility depending on a persons preference for daily versus weekly dosing and tablet versus injection form
Newer Doesnt Mean Safer Mounjaro and Zepbound are newer and may produce faster weight loss, but: They use the same gastric-slowing mechanism Long-term safety data is still limited Early reports suggest similar serious complications Being newer means manufacturers had access to earlier safety signals from semaglutide 4
Yes, all of these are subcutaneous injectable medications Patients self-administer the injections, typically once daily (Saxenda) or once weekly (Wegovy, Ozempic, Zepbound) A pharmacist or healthcare provider will teach proper injection technique Dose adjustments should not be done independently
